DC Circ. Tosses Watson's Appeal Of Vascepa FDA Remand
By Dani Kass ( December 10, 2015, 3:11 PM EST) -- The D.C. Circuit on Wednesday shot down Watson Laboratories Inc.'s premature attempt to appeal a district court order vacating the U.S. Food and Drug Administration's decision to limit market exclusivity for Amarin Pharmaceuticals Ireland Ltd.'s omega-3 drug Vascepa....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.